Evobiotix, with their professional senior Management having more than 25 years expertise in the pharmaceutical industry (within both small and big pharma companies) can help out Organisations and Investors understanding the value and risks of their assets from a developmental, regulatory and commercial point of view.

Our team can review regulatory, CMC and commercial information on behalf of Companies and Investors aiming to partnerships, acquisitions, merges, investments.

Our due diligence assistance encompass an approach that can be stand-alore or sequential, starting from a pre-diligence phase where we assess information that is available in the public domain and we perform a GAP analysis to evaluate whether there is a potential for an asset, followed by deeper evaluation steps where we can evaluate confidential information and perform a detailed analysis of the risks, with the implementation of confidential data room.

Upon request Evobiotix also also offers support for IP (Intellectual Property) protection within the biotechnology area, helping out Companies to overcome the multiple challenges related to obtaining IP protection.

In fact, biologics are derived from natural products, which creates a unique consideration in terms of obtaining protection when compared to traditional small molecules, such as difficulties in characterization, interlot variability, complex manufacturing processes.

Evobiotix, with its strong expertise and skills in the field of biotechnology can help to navigate the competitive and complex patent landscape helping Companies to complete their launch strategies.